XML 56 R45.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Compensation - Additional Information (Detail)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2019
USD ($)
plan
$ / shares
shares
Dec. 31, 2017
shares
Dec. 31, 2018
shares
Jun. 07, 2018
shares
Dec. 07, 2016
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of equity compensation plans | plan 3        
Additional awards granted (in shares) 753,010        
Weighted-average exercise price (in dollars per share) | $ / shares $ 32.96        
Options exercisable, weighted average remaining contractual life 5 years 8 months 5 days        
2005 Aerie Pharmaceutical Stock Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Additional awards granted (in shares) 0        
2013 Omnibus incentive plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Equity awards (in shares) 10,229,068     4,500,000  
Inducement Award Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Equity awards (in shares) 874,500       418,000
Employee Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense | $ $ 79.2        
Weighted-average remaining vesting period 2 years 10 months 10 days        
Restricted stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation expense related to unvested awards | $ $ 31.6        
Weighted-average of remaining vesting period 3 years 2 months 1 day        
Granted (in shares) 369,648        
Vested (in shares) 140,291        
Awards outstanding (in shares) 781,903   572,706    
Restricted stock | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based awards, vesting period 1 year        
Restricted stock | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock-based awards, vesting period 4 years        
Restricted Stock With Non-Market Performance Conditions          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Granted (in shares)   98,817      
Vested (in shares) 19,764        
Stock Appreciation Rights (SARs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Granted (in shares) 43,851        
Weighted-average exercise price (in dollars per share) | $ / shares $ 44.93        
Awards outstanding (in shares) 123,002        
Options exercisable, weighted average remaining contractual life 4 years 3 months 21 days